163 related articles for article (PubMed ID: 38789177)
1. Synergizing drug repurposing and target identification for neurodegenerative diseases.
Sahu M; Vashishth S; Kukreti N; Gulia A; Russell A; Ambasta RK; Kumar P
Prog Mol Biol Transl Sci; 2024; 205():111-169. PubMed ID: 38789177
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
3. Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.
Rani N; Kaushik A; Kardam S; Kag S; Raj VS; Ambasta RK; Kumar P
Prog Mol Biol Transl Sci; 2024; 205():23-70. PubMed ID: 38789181
[TBL] [Abstract][Full Text] [Related]
4. Insights into Computational Drug Repurposing for Neurodegenerative Disease.
Paranjpe MD; Taubes A; Sirota M
Trends Pharmacol Sci; 2019 Aug; 40(8):565-576. PubMed ID: 31326236
[TBL] [Abstract][Full Text] [Related]
5. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
6. Current approaches in identification of a novel drug targets for drug repurposing.
Khambhati K; Singh V
Prog Mol Biol Transl Sci; 2024; 205():213-220. PubMed ID: 38789179
[TBL] [Abstract][Full Text] [Related]
7. Drug repurposing for cancer therapy.
Xia Y; Sun M; Huang H; Jin WL
Signal Transduct Target Ther; 2024 Apr; 9(1):92. PubMed ID: 38637540
[TBL] [Abstract][Full Text] [Related]
8. Innovative target mining stratagems to navigate drug repurposing endeavours.
Saravanan KS; Satish KS; Saraswathy GR; Kuri U; Vastrad SJ; Giri R; Dsouza PL; Kumar AP; Nair G
Prog Mol Biol Transl Sci; 2024; 205():303-355. PubMed ID: 38789185
[TBL] [Abstract][Full Text] [Related]
9. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
[TBL] [Abstract][Full Text] [Related]
10. D
Savva K; Zachariou M; Bourdakou MM; Dietis N; Spyrou GM
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791356
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
12. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
[TBL] [Abstract][Full Text] [Related]
13. Current Small Molecule-Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics.
Sanghai N; Vuong B; Burak Berk A; Afridi MSK; Tranmer GK
ChemMedChem; 2024 May; 19(9):e202300705. PubMed ID: 38329887
[TBL] [Abstract][Full Text] [Related]
14. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
Jain P; Jain SK; Jain M
Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing from the perspective of pharmaceutical companies.
Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
[TBL] [Abstract][Full Text] [Related]
16. An update on Drug Repurposing: Re-written saga of the drug's fate.
Gns HS; Gr S; Murahari M; Krishnamurthy M
Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
[TBL] [Abstract][Full Text] [Related]
17. Drug repositioning and repurposing for Alzheimer disease.
Ballard C; Aarsland D; Cummings J; O'Brien J; Mills R; Molinuevo JL; Fladby T; Williams G; Doherty P; Corbett A; Sultana J
Nat Rev Neurol; 2020 Dec; 16(12):661-673. PubMed ID: 32939050
[TBL] [Abstract][Full Text] [Related]
18. Drug repurposing in silico screening platforms.
Mullins JGL
Biochem Soc Trans; 2022 Apr; 50(2):747-758. PubMed ID: 35285479
[TBL] [Abstract][Full Text] [Related]
19. Signature-based approaches for informed drug repurposing: targeting CNS disorders.
Shukla R; Henkel ND; Alganem K; Hamoud AR; Reigle J; Alnafisah RS; Eby HM; Imami AS; Creeden JF; Miruzzi SA; Meller J; Mccullumsmith RE
Neuropsychopharmacology; 2021 Jan; 46(1):116-130. PubMed ID: 32604402
[TBL] [Abstract][Full Text] [Related]
20. System biology approaches for drug repurposing.
Israr J; Alam S; Kumar A
Prog Mol Biol Transl Sci; 2024; 205():221-245. PubMed ID: 38789180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
